Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour

BACKGROUND: Biology-guided radiotherapy (BgRT) delivers dose to tumours triggered from positron emission tomography (PET) detection. Prostate specific membrane antigen (PSMA) PET uptake is abundant in the dominant intraprostatic lesion (DIL). This study investigates the feasibility of BgRT to PSMA-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudreault, Mathieu, Chang, David, Hardcastle, Nicholas, Jackson, Price, Kron, Tomas, Hofman, Michael S., Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156937/
https://www.ncbi.nlm.nih.gov/pubmed/35662883
http://dx.doi.org/10.1016/j.ctro.2022.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156937/
https://www.ncbi.nlm.nih.gov/pubmed/35662883
http://dx.doi.org/10.1016/j.ctro.2022.05.005

Ejemplares similares